|
|
|
| Influencing factors of cognitive disorder in elderly patients with atrial fibrillation who take oral Warfarin |
| BIAN Shuwei ZHOU Zhian▲ |
| Department of General Medicine, Chengde Central Hospital, Hebei Province, Chengde 067000, China |
|
|
|
|
Abstract Objective To investigate the influencing factors of cognitive disorder (CD) in elderly patients with oral Warfarin atrial fibrillation (AF). Methods A total of 121 patients with atrial fibrillation admitted to Chengde Central Hospital, Hebei Province from February 2019 to February 2022 were selected in a cross-sectional survey. The patients were divided into group without CD (59 cases) and group with CD (62 cases) by using the cognitive disorder rating scale (CDR). The drug use, medical history, and demographic data were collected. Logistic regression analysis was used to analyze the influencing factors of cognitive impairment, and receiver operating characteristic (ROC) curve was plotted to evaluate the predictive value of oral Warfarin in CD. Results There were significant differences in Warfarin anticoagulant stability, hypertension, diabetes, and left ventricular ejection fraction (LVEF) among patients with different CD patients (P＜0.05). Logistic regression analysis showed that hypertension (OR [95%CI] =3.003 [1.184, 7.617]), diabetes (OR [95%CI] =4.347 [1.756, 10.759]), Warfarin anticoagulation (OR [95%CI] =3.915 [1.572, 9.750]), and LVEF (OR [95%CI] =0.893 [0.826, 0.966]) were the influencing factors for CD in elderly patients with AF(P＜0.05). The area under the curve (AUC [95%CI]) of Warfarin anticoagulant treatment was 0.802 (0.725-0.879), and the sensitivity and specificity of CD were 83.9% and 62.7% when the maximum Jorden index was 0.466. Conclusion Diabetes, hypertension, warfarin anticoagulant treatment stability, LVEF are influencing factors for CD in patients with AF, Warfarin anticoagulant treatment stability has a good predictive value for CD in patients with AF.
|
|
|
|
|
|
[1] 王欢，王应昉，曹璐，等.某社区60岁及以上老年人群高血压患病率及相关因素分析[J].实用预防医学，2021，28（8）：967-970.
[2] Livingston G，Sommerlad A，Orgeta V，et al. The lancet international commission on dementia prevention and care [J]. Lancet，2017，390（10113）：2673-2734.
[3] 黄从新，张澍，黄德嘉，等.心房颤动：目前的认识和治疗的建议-2018[J].中国心脏起搏与心电生理杂志，2018， 32（4）：315-368.
[4] 郑声伟，庄梅.心房颤动患者抗凝治疗对相关认知功能影响的最新进展[J].心血管病学进展，2022，43（5）：411- 414.
[5] Lee E，Choi EK，Han KD，et al. Mortality and causes of death in patients with atrial fibrillation：a nationwide population- based study [J]. PLoS One，2018，13（12）：e0209687.
[6] Zeng D，Jiang CL，Su C，et al. Anticoagulation in atrial fibrillation and cognitive decline：a systematic review and meta- analysis [J]. Medicine，2019，98（7）：e14499.
[7] Mongkhon P，Fanning L，Lau WCY，et al. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation：a population-based cohort study [J]. Heart Rhythm，2020，17（5）：706-713.
[8] Madhavan M，Hu TY，Gersh BJ，et al. Efficacy of warfarin anticoagulation and incident dementia in a community-based cohort of atrial fibrillation [C]. Mayo Clin Proc Elsevier，2018， 93（2）：145-154.
[9] Papanastasiou CA，Theochari CA，Zareifopoulos N，et al. Atrial fibrillation is associated with cognitive impairment，all-cause dementia，vascular dementia，and Alzheimer’s disease：a systematic review and meta-analysis [J]. J Gen Intern Med，2021，36：3122-3135.
[10] 回翔，范晴晴，徐航，等.抗凝治疗对心房颤动患者认知功能障碍或痴呆发生影响的Meta分析[J].中国循环杂志，2019，34（11）：1103-1109.
[11] 李苏宁，陈祚，王增武，等.我国老年人高血压现状分析[J].中华高血压杂志，2019，27（2）：140-148.
[12] Tan S，Liu D，Zhang Y，et al. Trends in blood pressure and hypertension among older adults and oldest-old individuals in China between 2008-2018 [J]. Hypertens Res，2023：1-12.
[13] 杨郑，孙颖.老年心血管病与认知功能障碍的相关性[J].中华老年心脑血管病杂志，2017，19（1）：97-99.
[14] Ou YN，Tan CC，Shen XN，et al. Blood pressure and risks of cognitive impairment and dementia：a systematic review and meta-analysis of 209 prospective studies [J]. Hypertension，2020，76（1）：217-225.
[15] Verdecchia P，Angeli F，Reboldi G. Hypertension and atrial fibrillation：doubts and certainties from basic and clinical studies [J]. Circ Res，2018，122（2）：352-368.
[16] 王维维，申致远，李凡，等.高血压病合并脑小血管病的危险因素及与认知功能的关系[J].中国神经精神疾病杂志，2022，48（7）：392-397.
[17] 杨楠.基于静息态低频振幅探讨针刺神庭、百会对脑小血管病认知功能障碍的中枢机制[D].福州：福建中医药大学，2021：32-62.
[18] Lai Y，Jiang C，Du X，et al. Effect of intensive blood pressure control on the prevention of white matter hyperintensity：systematic review and meta-analysis of randomized trials [J]. J Clin Hypertens，2020，22（11）：1968-1973.
[19] 孙龙飞.握力、饮食与中老年人2型糖尿病患病率关系的研究[D].扬州：扬州大学，2022.
[20] 付永奇，刘晴晴，张艳，等.老年2型糖尿病患者血糖波动与认知功能障碍的关系[J].中国老年学杂志，2021， 41（14）：2946-2949.
[21] 李瑞方.2型糖尿病合并运动认知风险综合征患者的认知域特征及影响因素分析[D].赣州：赣南医学院，2022.
[22] 朱贺，殷实.认知障碍与抑郁症关系的研究进展[J].实用老年医学，2023，37（3）：234-237.
[23] Ding J，Strachan MWJ，Reynolds RM，et al. Diabetic retino- pathy and cognitive decline in older people with type 2 diabetes：the Edinburgh Type 2 Diabetes Study [J]. Diabetes，2010，59（11）：2883-2889.
[24] 冯广迅，杨艳敏，朱俊，等.心房颤动伴或不伴心力衰竭患者的死亡危险因素分析[J].中国循环杂志，2018，33（2）：161-165.
[25] 梁红，吕巍，杨依萌.认知障碍与心力衰竭的研究进展[J].中国老年学杂志，2021，41（22）：5149-5154.
[26] 刘莉，郭入嫣，邹国良，等.心力衰竭患者认知障碍的预测因素及治疗的研究进展[J].医学综述，2021，27（20）：4052-4057.
[27] Frey A，Sell R，Homola GA，et al. Cognitive deficits and related brain lesions in patients with chronic heart failure [J]. JACC Heart Failure，2018，6（7）：583-592. |
|
|
|
